Clinical Context
A typical patient is an adult presenting with acute hereditary angioedema (HAE) or an acute angioedema attack characterized by localized, non-pitting edema of the face, extremities, gastrointestinal tract (abdominal pain, vomiting), or upper airway swelling with potential airway compromise. The presenting workflow commonly occurs in an emergency department, urgent care clinic, infusion center, or outpatient specialty clinic where rapid symptom control is required.
A patient arrives with progressive facial swelling and difficulty breathing. After rapid assessment, airway status is monitored and intravenous access is established. The treating clinician (emergency physician, allergist/immunologist, or trained advanced practice provider) documents the diagnosis of acute HAE attack and administers a subcutaneous injection of J1744 (icatibant, 1 mg per unit). Observation follows for clinical response and potential adverse effects, with repeated dosing per product labeling if clinically indicated. Documentation includes indication, lot number, quantity administered (milligrams and total units), route (subcutaneous), site of administration, and any applicable modifier to reflect circumstances (e.g., partial administration, patient left against medical advice). Billing occurs under HCPCS Level II code J1744 with supporting ICD-10 diagnosis and any applicable procedural CPT codes for related services such as evaluation and management or airway management.